Årets vinnare inom hälsa korade på EIT Health Catapult 2022 i Stockholm

Årets vinnare inom hälsa korade på EIT Health Catapult 2022 i Stockholm

• Vinnarna i EIT Health Catapult 2022, utav 9 finalister, inom tre olika kategorier är: digital health start-up, Ebenbuild (Tyskland); medtech start-up, Leuko (Spain) och biotech start-up SolasCure (UK).

• Vinnarna utsågs under årets EIT Health Summit (24-25 maj) som för första gången gick av stapeln i Stockholm i samarbete

​€750 000 to EIT Health company Resitu Medical

The medical technology company Resitu Medical AB, working with an innovative solution for tumor biopsies, announced today that Almi Invest, Stockholm Business Angels (STOAF) and private investors have invested €750 000 in the company. The investment will be used to initiate a development project aiming for CE marking in 2023. An additional SEK 20 million will be raised through equity.

Six Scandinavian start-ups ready for EIT Health Catapult Semifinals

42 startups from across Europe with 6 based in Scandinavia have been selected for the EIT Health Catapult semi-finals with an €210 000 investment prize fund and the Audience Award Winner displayed on the New York Nasdaq Tower.